Arca Biopharma sell StockNews.com
Start price
25.03.23
/
50%
€1.84
Target price
25.03.24
-
Performance (%)
-14.49%
End price
26.03.24
€1.57
Summary
This prediction ended on 26.03.24 with a price of €1.57. The price of Arca Biopharma decreased from the start of the prediction. Compared to the start price this resulted in a performance of -14.49%. StockNews_com has a follow-up prediction for Arca Biopharma where he still thinks Arca Biopharma is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Arca Biopharma | -40.642% | -40.642% | 17.772% |
iShares Core DAX® | 1.560% | 2.566% | 18.261% |
iShares Nasdaq 100 | 0.517% | 1.894% | 25.521% |
iShares Nikkei 225® | 1.730% | 5.631% | 18.569% |
iShares S&P 500 | 1.482% | 1.594% | 24.989% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat
In the thread Trading Arca Biopharma
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten